Researchers from the NYU School of Medicine and Perlmutter Cancer Center have determined that blood tests that track the amount of tumor DNA—after just 1 month of treatment—detect how well treatment is working in patients with skin cancer.
Researchers from the NYU School of Medicine and Perlmutter Cancer Center have determined that blood tests that track the amount of tumor DNA—after just 1 month of treatment—detect how well treatment is working in patients with skin cancer.
During the study, the researchers traced circulating tumor DNA (ctDNA) for the cancer gene BRAF, which plays a role in various types of melanoma. They found that a tumor’s BRAF mutation could be detected by the new blood test in 93% of the patients before treatment started. After 1 month of therapy, BRAF ctDNA levels were no longer detectable in the 40% of patients who had a positive clinical outcome after targeted therapy.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen